Evidence map›Paper›PMID 35318362›Full record

ArticleScientific reports2022

Machine learning-aided design of composite mycotoxin detoxifier material for animal feed.

Giulia Lo Dico, Siska Croubels, Verónica Carcelén, Maciej Haranczyk

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Incidence of aflatoxin MVeterinarni medicina · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Giulia Lo Dico *IMDEA Materials Institute, C/Eric Kandel 2, 28906, Getafe, Madrid, Spain.
Siska Croubels *Department of Pathobiology, Pharmacology and Zoological Medicine, Faculty of Veterinary Medicine, Ghent University, Salisburylaan 133, 9820, Merelbeke, Belgium.ORCID 0000-0001-6357-3517
Verónica Carcelén *Tolsa Group, Carretera de Madrid a Rivas Jarama, 35, 28041, Madrid, Spain.
Maciej Haranczyk *IMDEA Materials Institute, C/Eric Kandel 2, 28906, Getafe, Madrid, Spain. maciej.haranczyk@imdea.org.ORCID 0000-0001-7146-9568

Funding

Young Adults and Drug Use: Careers and Familiar FactorsR01DA009819 · NIDA · EMORY UNIVERSITY · PI STERK, CLAIRE E · 1996 to 2004
$1.9M
6 · The paper itself

Abstract

The development of food and feed additives involves the design of materials with specific properties that enable the desired function while minimizing the adverse effects related with their interference with the concurrent complex biochemistry of the living organisms. Often, the development process is heavily dependent on costly and time-consuming in vitro and in vivo experiments. Herein, we present an approach to design clay-based composite materials for mycotoxin removal from animal feed. The approach can accommodate various material compositions and different toxin molecules. With application of machine learning trained on in vitro results of mycotoxin adsorption-desorption in the gastrointestinal tract, we have searched the space of possible composite material compositions to identify formulations with high removal capacity and gaining insights into their mode of action. An in vivo toxicokinetic study, based on the detection of biomarkers for mycotoxin-exposure in broilers, validated our findings by observing a significant reduction in systemic exposure to the challenging to be removed mycotoxin, i.e., deoxynivalenol (DON), when the optimal detoxifier is administrated to the animals. A mean reduction of 32% in the area under the plasma concentration-time curve of DON-sulphate was seen in the DON + detoxifier group compared to the DON group (P = 0.010).

Indexed as

MycotoxinsTrichothecenesAnimal FeedAnimalsChickensFood ContaminationMachine LearningMycotoxinsTrichothecenes

Identifiers

PMID35318362
PMCPMC8941095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.